Oscar Health, Inc. (OSCR) Research & Development Expenses
The r&d expense for Oscar Health, Inc. (OSCR) is $0 with a year-over-year change of 0.00%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
OSCR R&D Expense Chart
Current R&D Expense
$0
$0
Year-over-Year Change
0.00%
vs. $0 prior year
Historical Data
7
Years of data available
Annual R&D Expense History
| Year | R&D Expense | YoY Change | % Change |
|---|---|---|---|
| 2025 | $0 | +$0 | — |
| 2024 | $0 | +$0 | — |
| 2023 | $0 | +$0 | — |
| 2022 | $0 | +$0 | — |
| 2021 | $0 | +$0 | — |
| 2020 | $0 | +$0 | — |
| 2019 | $0 | — | — |
About Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Mark Thomas Bertolini